Cargando…

Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease

OBJECTIVE: To identify modifiers of age at diagnosis of Parkinson disease (PD). METHODS: Genome-wide association study (GWAS) included 1,950 individuals with PD from the NeuroGenetics Research Consortium (NGRC) study. Replication was conducted in the Parkinson's, Genes and Environment study, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallen, Zachary D., Chen, Honglei, Hill-Burns, Erin M., Factor, Stewart A., Zabetian, Cyrus P., Payami, Haydeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186025/ https://www.ncbi.nlm.nih.gov/pubmed/30338293 http://dx.doi.org/10.1212/NXG.0000000000000271

Ejemplares similares

Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
por: Hill-Burns, Erin M., et al.
Publicado: (2011)

Identification of a novel Parkinson’s disease locus via stratified genome-wide association study
por: Hill-Burns, Erin M, et al.
Publicado: (2014)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease
por: Hamza, Taye H., et al.
Publicado: (2014)

Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
por: Wallen, Zachary D., et al.
Publicado: (2020)

Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease
por: Hill-Burns, Erin M., et al.
Publicado: (2016)

A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease
por: Hill-Burns, Erin M., et al.
Publicado: (2012)

Population fraction of Parkinson’s disease attributable to preventable risk factors
por: Payami, Haydeh, et al.
Publicado: (2023)

LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
por: Stange, Lena, et al.
Publicado: (2022)

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
por: Wallen, Zachary D., et al.
Publicado: (2022)

Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee
por: Hamza, Taye H., et al.
Publicado: (2011)

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease
por: Hamza, Taye H, et al.
Publicado: (2010)

A linkage study of candidate loci in familial Parkinson's Disease
por: Wirdefeldt, Karin, et al.
Publicado: (2003)

DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient
por: Wang, Liyong, et al.
Publicado: (2016)

parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
por: Poorkaj, Parvoneh, et al.
Publicado: (2005)

PNPLA6‐Related Disorder with Levodopa‐Responsive Parkinsonism
por: Kazanci, Serdar, et al.
Publicado: (2022)

Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis
por: Ragland, Margaret, et al.
Publicado: (2009)

Resting-State Cerebello-Cortical Dysfunction in Parkinson's Disease
por: Palmer, William C., et al.
Publicado: (2021)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
por: Lill, Christina M., et al.
Publicado: (2012)

Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing
por: Wallen, Zachary D.
Publicado: (2021)

Stepping up to meet the challenge of freezing of gait in Parkinson’s disease
por: Lewis, Simon, et al.
Publicado: (2022)

Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry
por: Kim, Hojoong M., et al.
Publicado: (2018)

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2022)

Multivariate prediction of dementia in Parkinson’s disease
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020)

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease
por: Hossein-nezhad, Arash, et al.
Publicado: (2016)

Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain
por: Hill, Robert A., et al.
Publicado: (2018)

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
por: Tumas, Vitor, et al.
Publicado: (2016)

Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
por: Kim, Hojoong M., et al.
Publicado: (2019)

Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson’s Disease
por: Martino, Giovanni, et al.
Publicado: (2020)

Depressive symptoms before and after Parkinson’s diagnosis—A longitudinal analysis
por: Song, Shengfang, et al.
Publicado: (2022)

Freezing of Gait can persist after an acute levodopa challenge in Parkinson’s disease
por: Lucas McKay, J., et al.
Publicado: (2019)

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
por: Stewart, Tessandra, et al.
Publicado: (2015)

Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
por: Sheng, Lifu, et al.
Publicado: (2020)

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease
por: Mata, Ignacio F., et al.
Publicado: (2015)

Striatal Spine Plasticity in Parkinson's Disease
por: Villalba, Rosa M., et al.
Publicado: (2010)

Motor Cortical Plasticity in Parkinson’s Disease
por: Udupa, Kaviraja, et al.
Publicado: (2013)

Synaptic and cellular plasticity in Parkinson’s disease
por: Chu, Hong-Yuan
Publicado: (2020)

The Changing Landscape of Parkinson Epidemiologic Research
por: Chen, Honglei
Publicado: (2018)

Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
por: Richardson, R Mark, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1pmgrs7o67s4ii50h8hkee19n5